Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors
| Image |  |
|---|---|
| Description | scientific article published on 11 June 2018 |
| Author/s |
author: James R Manning |
| Publication date | June 11, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |